NasdaqGS - Nasdaq Real Time Price USD
Alnylam Pharmaceuticals, Inc. (ALNY)
267.55
+0.69
+(0.26%)
At close: May 14 at 4:00:02 PM EDT
267.55
0.00
(0.00%)
After hours: May 14 at 4:36:59 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-45,111
-8,312
104,156
-541,274
-641,693
Investing Cash Flow
64,549
-116,840
-336,350
169,354
-273,300
Financing Cash Flow
309,332
294,159
172,131
425,753
1,247,118
End Cash Position
1,013,489
968,652
814,884
868,556
822,153
Income Tax Paid Supplemental Data
15,342
14,360
6,021
2,654
--
Interest Paid Supplemental Data
103,566
67,578
32,118
45,235
24,657
Capital Expenditure
-30,274
-34,277
-62,211
-72,059
-76,372
Issuance of Capital Stock
--
--
--
0
0
Issuance of Debt
--
0
0
1,016,111
500,000
Repayment of Debt
--
0
0
-762,107
0
Free Cash Flow
-75,385
-42,589
41,945
-613,333
-718,065
12/31/2021 - 6/1/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IONS Ionis Pharmaceuticals, Inc.
32.60
+0.22%
ARGX argenx SE
532.27
-1.88%
ARWR Arrowhead Pharmaceuticals, Inc.
14.91
-2.42%
BMRN BioMarin Pharmaceutical Inc.
58.70
-1.81%
BBIO BridgeBio Pharma, Inc.
33.66
+1.20%
CYTK Cytokinetics, Incorporated
30.00
-1.99%
REGN Regeneron Pharmaceuticals, Inc.
571.36
-0.49%
VIR Vir Biotechnology, Inc.
4.5000
-4.26%
INSM Insmed Incorporated
65.61
-0.15%
APLS Apellis Pharmaceuticals, Inc.
16.70
-3.36%